COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (NASDAQ: SPNC) today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology. The study evaluated the safety and efficacy of laser assisted lead removal using the Spectranetics laser sheath (SLS® II).
